Cerner Co. (NASDAQ:CERN) has received a consensus recommendation of “Buy” from the twenty research firms that are presently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation and thirteen have given a buy recommendation to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $77.35.
Several equities analysts have issued reports on the stock. KeyCorp restated an “overweight” rating and set a $82.00 target price (up previously from $76.00) on shares of Cerner in a research note on Friday, August 16th. ValuEngine lowered shares of Cerner from a “buy” rating to a “hold” rating in a research note on Wednesday, September 4th. Bank of America set a $83.00 price objective on shares of Cerner and gave the company a “buy” rating in a report on Friday, October 25th. Deutsche Bank began coverage on shares of Cerner in a research report on Thursday, September 26th. They set a “buy” rating and a $82.00 price objective on the stock. Finally, UBS Group started coverage on shares of Cerner in a report on Tuesday, November 26th. They issued a “buy” rating and a $84.00 target price on the stock.
Shares of CERN stock traded down $0.47 during mid-day trading on Friday, hitting $70.60. The company’s stock had a trading volume of 1,637,429 shares, compared to its average volume of 2,074,754. The stock has a market cap of $22.20 billion, a price-to-earnings ratio of 31.95, a PEG ratio of 2.25 and a beta of 0.93. The company has a debt-to-equity ratio of 0.24, a quick ratio of 2.19 and a current ratio of 2.21. Cerner has a 52-week low of $48.78 and a 52-week high of $76.47. The business has a 50-day moving average price of $68.34 and a 200 day moving average price of $70.00.
In other news, CAO Michael R. Battaglioli sold 10,000 shares of the business’s stock in a transaction on Monday, November 25th. The shares were sold at an average price of $72.06, for a total transaction of $720,600.00. Following the completion of the sale, the chief accounting officer now owns 6,226 shares of the company’s stock, valued at approximately $448,645.56. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, COO Michael Nill sold 13,124 shares of the company’s stock in a transaction on Friday, September 13th. The stock was sold at an average price of $68.07, for a total value of $893,350.68. The disclosure for this sale can be found here. Insiders sold a total of 430,293 shares of company stock worth $29,118,407 in the last quarter. Company insiders own 0.75% of the company’s stock.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CERN. Smith Asset Management Group LP purchased a new position in shares of Cerner during the 2nd quarter valued at about $18,104,000. Janus Henderson Group PLC boosted its holdings in Cerner by 0.8% in the 2nd quarter. Janus Henderson Group PLC now owns 367,043 shares of the company’s stock worth $26,900,000 after buying an additional 2,859 shares during the period. Hartford Investment Management Co. increased its stake in Cerner by 0.3% in the 2nd quarter. Hartford Investment Management Co. now owns 104,219 shares of the company’s stock worth $7,639,000 after buying an additional 313 shares in the last quarter. FinTrust Capital Advisors LLC increased its stake in Cerner by 6,480.6% in the 2nd quarter. FinTrust Capital Advisors LLC now owns 8,160 shares of the company’s stock worth $598,000 after buying an additional 8,036 shares in the last quarter. Finally, State of Alaska Department of Revenue increased its stake in Cerner by 60.7% in the 3rd quarter. State of Alaska Department of Revenue now owns 81,249 shares of the company’s stock worth $5,537,000 after buying an additional 30,678 shares in the last quarter. Institutional investors own 81.62% of the company’s stock.
Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Featured Article: What Is An Exchange-Traded Fund (ETF)?
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.